-
1 Comment
Shandong Jincheng Pharmaceutical Group Co., Ltd is currently in a long term uptrend where the price is trading 34.9% above its 200 day moving average.
From a valuation standpoint, the stock is 17.8% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 3.3.
Shandong Jincheng Pharmaceutical Group Co., Ltd's total revenue sank by 2.8% to $664M since the same quarter in the previous year.
Its net income has dropped by 64.9% to $39M since the same quarter in the previous year.
Finally, its free cash flow grew by 26.2% to $122M since the same quarter in the previous year.
Based on the above factors, Shandong Jincheng Pharmaceutical Group Co., Ltd gets an overall score of 3/5.
| ISIN | CNE100001500 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Basic Materials |
| Industry | Chemicals |
| Beta | 0.59 |
|---|---|
| PE Ratio | 31.32 |
| Target Price | 5.54 |
| Dividend Yield | 1.9% |
| Market Cap | 6B |
Shandong Jincheng Pharmaceutical Group Co., Ltd researches and develops, produces, markets, and sells Cephalosporin intermediates in China and internationally. The company offers medical intermediate, animal nutrition, health care, CMO, CDMO, pharmaceuticals, API, finished dosage, and fine chemicals. Shandong Jincheng Pharmaceutical Group Co., Ltd was founded in 2004 and is based in Zibo, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300233.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
